Virginia Tech Carilion School of Medicine, Roanoke, VA.
Medstar Georgetown University Hospital, Washington, DC.
Ann Surg. 2019 Dec;270(6):976-982. doi: 10.1097/SLA.0000000000003127.
To determine the influence of initial prescription size on opioid consumption after minor hand surgeries. Secondary outcomes include efficacy of pain control, patient satisfaction, and refill requests.
Retrospective studies have shown that opioid prescriptions for acute pain after surgical procedures are often excessive in size, which encourages misuse. This is the first prospective randomized trial on the influence of initial prescription size on opioid consumption in the setting of acute postsurgical pain.
In a prospective randomized trial at a single-academic institution, patients were provided an initial prescription of either 10 or 30 hydrocodone/acetaminophen (5/325 mg) pills after surgery. Two hundred opioid-naive patients, aged 19 to 69, undergoing elective outpatient minor hand surgeries were enrolled over 9 months, with a follow-up period of 10 to 14 days.
One hundred seventy-four patients were included in this analysis. Patients initially prescribed 30 pills (n = 79), when compared with patients initially prescribed 10 pills (n = 95), used significantly more opioid (P = <0.001, mean 11.9 vs 6.4 pills), had significantly more leftover medication (P = <0.001, mean 20.0 vs 5.2 pills), and were over 3 times more likely to still be taking opioid at follow-up (15% vs 4%). There was no significant difference in refills requested, or in patient satisfaction with postoperative pain control.
Providing large opioid prescriptions for the management of acute pain after minor upper extremity surgeries increases overall opioid use when compared with smaller initial prescriptions. The size of initial opioid prescription is a modifiable variable that should be considered both in patient care and research design.
确定小手部手术后初始处方剂量对阿片类药物消耗的影响。次要结果包括疼痛控制效果、患者满意度和续药请求。
回顾性研究表明,手术后急性疼痛的阿片类药物处方往往过大,这鼓励了滥用。这是第一项关于初始处方剂量对急性手术后疼痛中阿片类药物消耗影响的前瞻性随机试验。
在单所学术机构的前瞻性随机试验中,术后患者提供 10 或 30 片氢可酮/对乙酰氨基酚(5/325mg)的初始处方。9 个月期间,共招募了 200 名年龄在 19 至 69 岁之间、接受择期门诊小手部手术的阿片类药物初治患者,随访期为 10 至 14 天。
174 名患者纳入本分析。与初始处方 10 片的患者(n=95)相比,初始处方 30 片的患者(n=79)使用的阿片类药物明显更多(P<0.001,平均 11.9 对 6.4 片),剩余药物明显更多(P<0.001,平均 20.0 对 5.2 片),在随访时仍在服用阿片类药物的可能性高出 3 倍以上(15%对 4%)。续药请求或患者对术后疼痛控制的满意度无显著差异。
与较小的初始处方相比,为小上肢手术后急性疼痛管理提供大剂量阿片类药物处方会增加整体阿片类药物使用。初始阿片类药物处方的大小是一个可改变的变量,应在患者护理和研究设计中都考虑到。